# Insmed (stock symbol: INSM) Logo in transparent PNG format

## Insmed Logo large

### Insmed Logo large Download PNG (47.46 KB)

![Insmed Logo large Download PNG (47.46 KB)](/img/orig/INSM_BIG-36ddd320.png)

## Insmed Logo icon format

### Insmed Logo icon format Download PNG (23.2 KB)

![Insmed Logo icon format Download PNG (23.2 KB)](/img/orig/INSM-e49de6a0.png)

## About Insmed

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.

1. Website domain: insmed.com
2. Employees: 613
3. Marketcap: $2.66 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
